#None #Japan #Eitan Medical #ParagonCare #Sapphire Pump

Eitan Medical Introduces the Sapphire™ Infusion Pump System in Japan

Eitan Medical, renowned for its innovative advancements in infusion therapy and drug delivery solutions, has taken a monumental step in expanding its global presence by launching the Sapphire™ Infusion Pump System in Japan. This introduction follows the attainment of regulatory approval from Japan's Pharmaceuticals and Medical Devices Agency (PMDA) and signifies a substantial milestone in the company’s mission to provide cutting-edge infusion solutions to healthcare providers and patients globally.

Japan is recognized as one of the largest medical device markets in the world, characterized by a rapidly aging demographic and a healthcare system that prides itself on high-quality standards. The Sapphire™ infusion platform aims to meet the increasing demand for advanced infusion technology that seamlessly supports patients throughout various care settings—hospital, ambulatory, and homecare. By consolidating multiple functionalities onto a single platform, the Sapphire™ system enhances clinician workflow and treatment efficacy without compromising patient safety.

Key Features of the Sapphire™ Infusion Pump System

The Sapphire™ infusion pump system stands out as Eitan Medical’s flagship product, specifically engineered to deliver a wide array of therapies across diverse clinical environments. With its compact and lightweight design, the system features a full-color touch screen that has been fully localized for Japanese users, ensuring fast and intuitive operation. The versatility of the device is further exemplified by its capacity to accommodate six adaptable delivery modes—including Continuous, PCA, Intermittent, Multistep, TPN, and Epidural—allowing it to manage acute care, pain management, and nutritional therapy through a single device.

Notably, the Sapphire™ platform addresses the unique needs of immunoglobulin therapy in Japan. This feature facilitates both intravenous and subcutaneous immunoglobulin infusion regimens, enabling the management of complex multistep infusion protocols and accommodating various flow rates tailored for patients with immunodeficiencies and neurological disorders, both in healthcare facilities and, when appropriate, at home.

The integration of advanced safety mechanisms, such as an anti-free-flow system, air-in-line detection, and an embedded drug library, reinforces Eitan Medical’s unwavering commitment to patient safety and operational efficiency.

Insights from Eitan Medical's Leadership

Roger Massengale, Eitan Medical's Chief Commercial Officer, expressed his enthusiastic outlook regarding this market entry, stating, "Reaching the Japanese market is a defining moment for Eitan Medical, and for the patients we serve. Japan holds the world to its highest standards in medical device performance, and earning a place in that market is a validation of everything we stand for—relentless innovation, uncompromising safety, and the conviction that where a patient receives care should never limit the quality of that care."

Yasuaki Nakamura, General Manager at ParagonCare Japan, also highlighted the benefits of the Sapphire™ system, remarking, "Japanese hospitals handle some of the most demanding infusion protocols globally, which often require multiple pumps. The Sapphire™ integrates these therapies onto one platform without compromising safety or ease of use. We are eager to introduce this technology to hospitals and care providers across Japan and support our customers in achieving better outcomes for their patients."

Conclusion

With the launch of the Sapphire™ infusion pump system, Eitan Medical not only enhances the standard of infusion therapy in Japan but also establishes a long-term partnership with clinicians and patients alike. For further details about the Sapphire™ infusion system or other Eitan Medical innovations, please visit www.eitanmedical.com.

In essence, Eitan Medical's introduction of the Sapphire™ pump in Japan signifies a leap forward in the realm of infusion therapy—a step towards better access and improved treatment outcomes across the Asia-Pacific region.